| Excerpt | Reference |
|---|
| "A case of parathyroid carcinoma is described which presented with severe bone disease, complicated after parathyroidectomy by symptomatic hypocalcaemia and magnesium deficiency, both of which responded dramatically to the administration of magnesium." | ( Falconer, CW; Fitzpatrick, K; Proter, GM; Scott, RD, 1976) |
| "A parathyroid adenoma is reported in a girl aged 12 years in whom hypercalcaemia was discovered by chance." | ( Bouissou, H; Dutau, G; Manelfe, C; Ribot, C; Rochiccioli, P, 1977) |
| "A case of parathyroid carcinoma is presented in which the patient had a high serum calcium level, a palpable tumor with invasion of the thyroid gland and metastasis to a local lymph node." | ( Boehm, G; McGarity, WC, 1975) |
| "Parathyroid carcinoma is often the real cause but, because of its rarity, sometimes it is either overlooked or misdiagnosed." | ( Fronistas, O; Manolas, C; Stavraka-Kakavaki, A; Toumbouros, M, 1992) |
| "Parathyroid carcinoma is a rare clinical entity accounting for only 4 per cent of all cases of parathyroid neoplasia." | ( Karulf, RE; Klink, BK; Maimon, WN; Peoples, JB, 1991) |
| "Treatment for a parathyroid adenoma is removal of the tumor and identification of the normal parathyroid glands." | ( Clark, OH; Duh, QY, 1989) |
| "Human parathyroid adenomas are aberrantly regulated by extracellular calcium." | ( Aurbach, GD; Fitzpatrick, LA; Martin, C; Norton, J; Sharp, M, 1988) |
| "Parathyroid carcinoma is a slow growing tumor, and the patients most often die from complications to the hypercalcemia." | ( Blichert-Toft, M; Krøll, L; Ladefoged, C; Qvist, N; Rohr, N, 1986) |
| "Acceptable cases of parathyroid carcinoma are rare, but carcinoma is an important cause of recurrent hyperparathyroidism even months or years after removal of an ;adenoma'." | ( Ellis, HA; Floyd, M; Herbert, FK, 1971) |
| "The parathyroid carcinoma is a rare cause of primary hyperparathyroidism." | ( Baczako, K; Gottswinter, JM; Herfarth, C; Heymer, B; Weise, HJ; Ziegler, R, 1984) |
| "Parathyroid carcinoma is a rare cause of hyperparathyroidism." | ( Calandra, DB; Chejfec, G; Foy, BK; Lawrence, AM; Paloyan, E, 1984) |
| "Parathyroid carcinoma is a rare disease entity associated with a much more severe course and prognosis than parathyroid adenomas; it has not been reported in a pregnant woman." | ( Dickson, J; Fox, HE; Hess, HM, 1980) |
| "Parathyroid carcinoma is rare and the associated hypercalcaemia is often resistant to all treatment." | ( Braatvedt, GD; Corrall, RJ; Newrick, PG; Sheffield, E; Webb, AJ, 1994) |
| "A case of a parathyroid adenoma is presented in which the conventional Tl-201 minus Tc-99m subtraction technique failed to localize the adenoma because of prior iodide administration and a low Tl-201 uptake." | ( De Feyter, I; Lippens, M; Obrie, E; Osmanagaoglu, K; Schelstraete, K, 1993) |
| "A patient with parathyroid cancer is presented who underwent Tc-99m MIBI scintigraphy." | ( Barista, I; Bekdik, C; Caner, B; Kars, A; Kitapçi, MT; Tastekin, G; Turgut, M, 1993) |
| "Parathyroid carcinoma is a rare cause for primary hyperparathyroidism." | ( Esselstyn, CB; Kim, EY; Neumann, DR, 1996) |
| "Parathyroid carcinoma is one cause of primary hyperparathyroidism, a condition in which there is hypercalcemia and dysregulated hypersecretion of PTH." | ( Bilezikian, JP; Collins, MT; Marx, SJ; Silverberg, SJ; Skarulis, MC; Spiegel, AM, 1998) |
| "Parathyroid carcinoma is a rare cause of hyperparathyroidism and metabolic osteopathy." | ( Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J, 1998) |
| "Parathyroid cancer is very rare in chronic renal failure." | ( Collin, P; Djema, AI; Heymann, MF; Mahmoud, MD, 1998) |
| "Parathyroid adenomas are embedded within thyroid tissue in about 2-5% of cases." | ( André, M; André, V; Forlodou, P; Garcia, JF; Granier, H; Le Dreff, P, 1999) |
| "Parathyroid carcinoma is a rare cause of primary hyperparathyroidism." | ( Boquist, L; Kristoffersson, A; Rasmuson, T, 2000) |
| "Parathyroid carcinoma is a rare and difficult diagnosis to make based on the histological features alone." | ( Crotty, TB; Hill, AD; McDermott, EW; O'Higgins, NJ; Sheehan, JJ; Walsh, MF, 2001) |
| "Parathyroid adenomas are benign uniglandular tumors and are the most common cause of primary hyperparathyroidism." | ( Asahara, T; Fujimori, M; Ikeda, S; Ishizaki, Y; Ojima, Y; Okajima, M; Shimizu, Y; Sugino, K, 2002) |
| "Although parathyroid neoplasms are common and cause primary hyperparathyroidism, parathyroid carcinoma is a rare entity." | ( Kebebew, E, 2001) |
| "Parathyroid carcinoma is an uncommon endocrine malignancy, with difficult diagnosis." | ( Atienza Iglesias, MA; Sillero Sánchez, A, 2002) |
| "Parathyroid cancer is rare but relatively frequent in Japan compared to Western countries." | ( Chen, Q; Chihara, K; Kaji, H; Kobayashi, A; Nomura, R; Sowa, H; Sugimoto, T; Tsukamoto, T; Yamaguchi, T; Yamauchi, M, 2003) |
| "Parathyroid carcinoma is a rare cause of primary hyperparathyroidism, and the efficacy of medical therapy and chemo- and radiotherapy is poor in recurrent or metastatic disease." | ( Beckers, A; Betea, D; Bradwell, AR; Daly, AF; Ghaye, B; Harvey, TC; Mead, GP; Schmidt-Gayk, H, 2004) |
| "The incidence of parathyroid carcinoma is approximately 0." | ( Clark, P; Kleinpeter, K; Lovato, J; Morton, K; Perrier, N; Wooldridge, T, 2004) |
| "Parathyroid carcinoma is an uncommon malignancy." | ( McHenry, CR; Mittendorf, EA, 2005) |
| "Parathyroid carcinoma is a rare malignancy with a wide range of aggressiveness." | ( Bergman, S; Clark, PB; Kleinpeter, KP; Lovato, JF; Norman, ES; Perrier, ND; Wooldridge, T, 2005) |
| "(2) Parathyroid cancer is a rare malignancy frequently associated with hypercalcaemia." | ( , 2006) |
| "Parathyroid adenoma is the most common cause of primary hyperparathyroidism." | ( Koksal, H; Kurukahvecioglu, O; Taneri, F; Yazicioglu, MO, 2006) |
| "Parathyroid cancer is a rare endocrine tumor and an uncommon cause of HPT." | ( Lang, B; Lo, CY, 2006) |
| "Intrathyroidal parathyroid carcinoma is an exceedingly rare cause of primary hyperparathyroidism with difficulties in the diagnosis and management." | ( Al-Sanea, O; El-Maghraby, TA; Hussein, WI, 2006) |
| "Patients with parathyroid cancer are frequently plagued by severe hypercalcemia, which is often refractory to medical therapy." | ( Headley, RC; Kaplan, EL; Melis, M; Mezhir, JJ; Pai, RK; Posner, MC, 2007) |
| "Parathyroid carcinoma is often misdiagnosed as thyroid carcinoma clinically and also with fine needle aspiration cytology." | ( Dasiah, SD; Ramdas, A; Toi, PCh; Varghese, RG, 2007) |
| "Parathyroid adenomas are the main reason for this disorder and can frequently be detected by ultrasound examination." | ( Fritzen, R; Scherbaum, WA; Schinner, S; Schott, M; Willenberg, HS, 2007) |
| "Parathyroid carcinoma is a rare endocrine tumour accounting for only about one of every hundred cases of primary hyperparathyroidism." | ( Krysiak, R; Okopień, B, 2007) |
| "Mediastinal parathyroid carcinoma is very rare regardless of whether it is functioning, and it is sometimes problematic in both diagnosis and treatment." | ( Inoue, K; Iwata, T; Mizuguchi, S; Morita, R; Onoda, N; Suehiro, S; Tsukioka, T, 2008) |
| "Parathyroid carcinoma is a rare malignancy, and only accounts for 0." | ( Lewis, JS; Wilkins, BJ, 2009) |
| "Intraneural parathyroid adenomas are extremely rare, with only 9 cases of intravagal adenomas reported." | ( Flaris, N; Karvounaris, DC; Sakadamis, A; Symeonidis, N; Triantafyllou, A, 2010) |
| "Parathyroid carcinoma is an indolent but ultimately life-threatening malignancy." | ( Adam, MA; Olson, JA; Untch, BR, 2010) |
| "Ectopic parathyroid adenomas are rare, but they can complicate the surgical treatment and have an increased morbidity and poorer success rate." | ( Aliyev, A; Halac, M; Kabasakal, L; Paksoy, M; Simsek, O; Uslu, I, 2010) |
| "Parathyroid carcinoma is a rare malignancy, accounting for about 1% of primary hyperparathyroidism." | ( Li, JY; Yong, TY, 2010) |
| "The diagnosis of parathyroid carcinoma is established according to severe hypercalcemia, clinical features, subset B-ultrasound and Tc(99m)-sestamibi scanning, intraoperative finding of adherence to close structures and histopathology." | ( Chen, LR; Li, GG; Li, ZY; Wang, P; Xu, SM, 2010) |
| "Parathyroid carcinoma is a rare malignancy and generally is diagnosed after surgery for primary hyperparathyroidism." | ( Aben, KK; Haak, HR; Jorna, FH; Links, TP; Plukker, JT; Schaapveld, M, 2011) |
| "Parathyroid carcinomas are very rare tumors and may arise in the normally located or ectopic gland." | ( Cook, MI; Cummins, RS; Qureshi, YA; Todd, CE, 2012) |
| "Parathyroid cancer is rare, but often fatal, as preoperative identification of malignancy against the backdrop of benign parathyroid disease is challenging." | ( Schulte, KM; Talat, N, 2012) |
| "Parathyroid carcinoma is a rare endocrine malignancy with an estimated incidence of less than 1 per million population." | ( Birol, I; Chuah, E; Corbett, RD; He, A; Hirst, M; Jones, SJ; Kasaian, K; Marra, MA; McDonald, H; Moore, RA; Mungall, AJ; Mungall, KL; Nip, KM; Pandoh, P; Qian, JQ; Schein, J; Tam, A; Thiessen, N; Tse, K; Varhol, RJ; Walker, BA; Wiseman, SM; Zeng, T; Zhao, Y, 2013) |
| "Parathyroid carcinoma is a rare malignant endocrine tumor accounting for only 0." | ( Buiga, R; Irimie, A; Kontogeorgos, G; Piciu, A; Piciu, D, 2013) |
| "Parathyroid cancer is rare." | ( Aspinall, SR; Bliss, RD; Johnson, SJ; Lennard, TW; Truran, PP, 2014) |
| "Parathyroid carcinoma is a rare tumor typically presenting with marked elevations of serum calcium concentrations and associated renal and skeletal symptoms." | ( Cincibuch, J; Frysak, Z; Geierova, M; Kaminek, M; Klein, J; Melichar, B; Studentova, H, 2015) |
| "Parathyroid adenomas are comprised of distinct cellular subpopulations of variable clonal status that exhibit differing degrees of calcium responsiveness." | ( Allbritton, NL; DiSalvo, M; Hogue, JA; Koh, J; Olson, JA; Shi, Y; Sosa, JA; Wang, Y, 2016) |
| "Parathyroid adenoma is the main cause of primary hyperparathyroidism." | ( Khan, HA; Latif, A; Malik, A; Rashid, A; Zil-E-Ali, A, 2016) |
| "Parathyroid cancer is rare (<1-5 %)." | ( Barazeghi, E; Dina, R; Gill, AJ; Hellman, P; Norlén, O; Palazzo, FF; Sidhu, S; Stålberg, P; Westin, G, 2016) |
| "Intrathymic parathyroid adenoma is a rare cause of primary hyperparathyroidism." | ( Abu Huda, F; Al Kandari, F; Amanguno, HG; Javaid, A; Oteifa, M; Usmani, S, 2016) |
| "Parathyroid cancer is an uncommon type of malignancy, which is frequently associated with poor prognosis." | ( Buchpiguel, CA; Coutinho, AM; de Menezes, MR; do Vale, RH; Queiroz, MA, 2016) |
| "Ectopic parathyroid adenomas are considered the main cause of primary hyperparathyroidism." | ( Abu Abeeleh, M; Alodwan, T; Alshehabat, M; Bani Hani, A; Bani Ismail, Z; Ghaith, A, 2016) |
| "2% of ectopic parathyroid adenomas are not accessible to standard cervical excision." | ( Al-Kutoubi, A; Khalife, M; Salman, R; Sebaaly, MG; Sfeir, P; Wehbe, MR, 2017) |
| "Parathyroid carcinoma is a very rare malignant tumor of the parathyroid gland." | ( Jellali, S; Kolsi, N; Koubaa, J, 2017) |
| "Parathyroid carcinoma is a rare cause of hyperparathyroidism in end-stage kidney disease." | ( Fuse, M; Kada, S; Takada, D; Tsukamoto, T; Yanagita, M, 2017) |
| "Parathyroid carcinoma is a rare endocrine malignancy." | ( Fang, L; Gao, Y; Xiang, F; Xie, M; Yu, C, 2017) |
| "Undescended parathyroid adenomas are rare, and they are easily missed during neck exploration surgery in patients with hyperparathyroidism." | ( Mahajan, S; Schoder, H, 2018) |
| "Parathyroid carcinoma is thus usually diagnosed incidentally based on nonspecific multiorgan symptoms of hypercalcemia and hyperparathyroidism." | ( Chen, Z; Fu, J; Shao, Q; Wang, F; Zhou, B, 2018) |
| "Parathyroid carcinoma is uncommon, and its coexistence with parathyroid adenoma is extremely rare." | ( Huang, L; Li, J; Li, Y; Yang, J; Yang, P, 2019) |
| "Parathyroid carcinoma is the rarest endocrine malignancy." | ( Abdulla, S; Jacob, A; Shamil, E; Wilsher, M, 2019) |
| "Parathyroid carcinoma is a rare malignancy with an increasing incidence." | ( Cao, H; Wang, W, 2019) |
| "Ectopic parathyroid adenomas are a common cause of postsurgical persistent primary hyperparathyroidism." | ( Beylergil, V; Hsieh, MP; Nemer, JS; Yeh, R, 2020) |
| "Parathyroid cancer is a rare malignancy and an uncommon cause of hyperparathyroidism." | ( Apaydın, T; Yavuz, DG, 2021) |
| "Parathyroid adenoma is responsible for 80-85% of cases of primary hyperparathyroidism." | ( Alay, M; Ercek, BM; Sakin, A; Sonmez, GM; Ucler, R; Yildiz, S, 2020) |
| "Single parathyroid adenoma is the main cause of primary hyperparathyroidism (PHPT), with surgery remaining the gold standard for its treatment." | ( Dotzenrath, C; Papadakis, M; Weyerbrock, N; Zirngibl, H, 2020) |
| "Parathyroid carcinoma is a rare neuroendocrine tumor." | ( Bell, D; Gule-Monroe, M; Khalil, M; Sherman, SI; Zafereo, M, 2021) |
| "Water-clear cell parathyroid adenoma is an uncommon cause of primary hyperparathyroidism." | ( Cheng, SP; Dai, SH; Lin, JL; Yang, CA, 2022) |
| "Atypical parathyroid adenoma is a term applied to a neoplasm with 'worrisome' features but not fulfilling the 'absolute histopathological criteria of malignancy'." | ( Agarwal, S; Alam, S; Boro, H; Khadgawat, R; Khatiwada, S; Kubihal, S; Kubihal, V, 2022) |
| "Parathyroid carcinoma is a rare form of primary hyperparathyroidism that may be associated with PTH dependent hypercalcemia." | ( Nowak, G; Sanchez, B; Scheen, M; Teta, D, 2022) |
| "Parathyroid adenoma is the most frequent cause of primary hyperparathyroidism." | ( Amaral, S; Carrilho, N; Coutinho, JM; Palha, A; Rego, T; Silva-Nunes, J; Tavares, P, 2023) |
| "Parathyroid carcinoma is an uncommon cause of PTH-dependent hypercalcemia." | ( Anandagoda, G; Dematapitiya, C; Dissanayaka, V; Dissanayake, P; Gamage, K; Pathmanathan, S; Perera, C; Subasinghe, V; Sumanatilleke, M; Wijenayake, U; Wijewickrama, P, 2022) |
| "Most patients with parathyroid adenomas are asymptomatic and rarely present with chronic pancreatitis (CP)." | ( Chen, HF; Fu, CH, 2022) |
| "Most patients with parathyroid adenomas are asymptomatic and rarely present with chronic pancreatitis (CP)." | ( Chen, HF; Fu, CH, 2022) |
| "Most patients with parathyroid adenomas are asymptomatic and rarely present with chronic pancreatitis (CP)." | ( Chen, HF; Fu, CH, 2022) |
| "Large parathyroid adenomas are often associated with more severe form of the disease, including osteitis fibrosa cystica (OFC) and share many biochemical, histological, and molecular features of both benign and malignant parathyroid neoplasms, and are considered a distinct clinical entity." | ( Athimulam, S; Bhadada, SK; Bhan, A; Cook, BC; Kumari, P; Pal, R; Qiu, S; Rao, SD, 2023) |
| "Parathyroid carcinoma is a rare disease with a frequency of 0." | ( Rino, Y; Suganuma, N; Yokoyama, K, 2023) |
| Excerpt | Reference |
|---|
| "A case of parathyroid carcinoma is described which presented with severe bone disease, complicated after parathyroidectomy by symptomatic hypocalcaemia and magnesium deficiency, both of which responded dramatically to the administration of magnesium." | ( Falconer, CW; Fitzpatrick, K; Proter, GM; Scott, RD, 1976) |
| "Of these, 1 patient appeared cured of parathyroid carcinoma by radiation therapy 11 years after documented tumor invasion of his trachea." | ( Carney, JA; Fitzpatrick, LA; van Heerden, J; Wynne, AG, 1992) |
| "Treatment for a parathyroid adenoma is removal of the tumor and identification of the normal parathyroid glands." | ( Clark, OH; Duh, QY, 1989) |
| "A single case of nonfunctioning parathyroid carcinoma responding to treatment with methotrexate, Adriamycin, cyclophosphamide, and CCNU has been reported." | ( Calandra, DB; Chejfec, G; Foy, BK; Lawrence, AM; Paloyan, E, 1984) |
| "A 54-year-old patient with metastatic parathyroid carcinoma and severe hypercalcemia refractory to conventional treatment was treated with chemotherapy consisting of fluorouracil, 500 mg/sq m intravenously (IV) daily for four days (24-hour infusion), cyclophosphamide, 500 mg/sq m IV daily for four days, and dacarbazine (imidazole carboxamide), 200 mg/sq m IV daily for four days." | ( Bukowski, RM; Cunningham, J; Esselstyn, C; Sheeler, L, 1984) |
| "Recurrence of surgically treated parathyroid cancer occurs in 30% to 65% of patients and has a poor prognosis; only 1 of 29 cases remained normocalcemic more than 2 years later." | ( Baumgartner, CJ; Britt, LG; Palmieri, GM; Palmieri-Sevier, A, 1993) |
| "A case of a parathyroid adenoma is presented in which the conventional Tl-201 minus Tc-99m subtraction technique failed to localize the adenoma because of prior iodide administration and a low Tl-201 uptake." | ( De Feyter, I; Lippens, M; Obrie, E; Osmanagaoglu, K; Schelstraete, K, 1993) |
| "We report on a patient with parathyroid carcinoma with hypercalcaemia and pulmonary metastases, treated with pamidronate and radiotherapy and later with surgery." | ( Boquist, L; Kristoffersson, A; Rasmuson, T, 2000) |
| "1) an increased frequency of parathyroid adenoma was found in BC patients with mildly aggressive neoplastic disease; 2) in BC patients with no evidence of primary hyperparathyroidism mean serum PTH and calcium concentrations were significantly greater than in healthy controls and in patients with thyroid carcinoma; and 3) this finding was unrelated to clinical staging or anti-tumor therapy." | ( Conte, PF; Fierabracci, P; Giani, C; Marcocci, C; Miccoli, P; Pinchera, A; Vignali, E; Zaccagnini, M, 2001) |
| "Eighteen patients treated for parathyroid carcinoma from 1966 to 1999." | ( Arici, C; Clark, OH; Duh, QY; Kebebew, E, 2001) |
| "(5) The assessment of treatment of parathyroid cancer is limited to one ongoing non comparative trial involving 21 patients." | ( , 2006) |
| "We studied 8 patients with parathyroid carcinoma before and at week 16 of cinacalcet therapy, 6 patients with PHPT, and 6 control individuals." | ( Bilezikian, JP; Brossard, JH; Cantor, T; D'Amour, P; Rousseau, L; Rubin, MR; Silverberg, SJ; Sliney, J, 2007) |
| "N-PTH is overproduced in some parathyroid cancer patients, but calcimimetic therapy does not influence its production." | ( Bilezikian, JP; Brossard, JH; Cantor, T; D'Amour, P; Rousseau, L; Rubin, MR; Silverberg, SJ; Sliney, J, 2007) |
| "Patients with parathyroid cancer are frequently plagued by severe hypercalcemia, which is often refractory to medical therapy." | ( Headley, RC; Kaplan, EL; Melis, M; Mezhir, JJ; Pai, RK; Posner, MC, 2007) |
| "Management of inoperable parathyroid carcinoma presents a challenge because until recently, effective medical therapy was not available." | ( Bilezikian, JP; Faiman, C; Klassen, P; Olson, KA; Peacock, M; Rubin, MR; Schwanauer, LE; Shoback, DM; Silverberg, SJ; Smallridge, RC, 2007) |
| "Mediastinal parathyroid carcinoma is very rare regardless of whether it is functioning, and it is sometimes problematic in both diagnosis and treatment." | ( Inoue, K; Iwata, T; Mizuguchi, S; Morita, R; Onoda, N; Suehiro, S; Tsukioka, T, 2008) |
| "Ectopic parathyroid adenomas are rare, but they can complicate the surgical treatment and have an increased morbidity and poorer success rate." | ( Aliyev, A; Halac, M; Kabasakal, L; Paksoy, M; Simsek, O; Uslu, I, 2010) |
| "The clinical data of 9 cases of parathyroid carcinoma treated from January 1967 to December 2009 was analyzed retrospectively with the review of related Chinese literatures." | ( Chen, LR; Li, GG; Li, ZY; Wang, P; Xu, SM, 2010) |
| "Single parathyroid adenoma is the main cause of primary hyperparathyroidism (PHPT), with surgery remaining the gold standard for its treatment." | ( Dotzenrath, C; Papadakis, M; Weyerbrock, N; Zirngibl, H, 2020) |
| "A total of 12 PHPT patients with parathyroid adenoma were treated with MWA in Nanjing University of Chinese Medicine Affiliated Hospital of Integrated Traditional Chinese and Western Medicine from May 2019 to February 2021." | ( Chen, GF; Chu, XQ; Han, X; Liu, C; Lu, CY; Ni, WJ; Wang, JH; Wu, XP; Xu, SH; Xu, Y, 2021) |
| "To study treatment outcome of parathyroid adenomas using ultrasound-guided radiofrequency ablation." | ( Azimi Aval, MR; Beiranvand, B; Chegeni, H; Deldar Pasikhani, M; Ebrahiminik, H; Fadaee, N; Ghomashchi, G; Heydari, I; Mirza-Aghazadeh-Attari, M; Mohammadi, A; Mosadegh Khah, A; Salouti, R; Shamsi, K, 2022) |
| "To review the features and treatment of parathyroid cancer in our series." | ( Dai, L; Wang, C; Wen, K; Wen, S; Zhang, Y, 2022) |